Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Amino Acid Ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1260364C reveals a novel enzymatic hydrolysis using bulky esters for high-purity beta-amino acids, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced Ir-catalyzed asymmetric hydrogenation for beta-amino acid esters. Delivers 99% ee and 95% yield. Reliable pharmaceutical intermediates supplier for scalable production.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.